Loading the session
Loading the session
Loading instrument
$136.80
+0.21%Delayed · Pre-marketDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 19:18 IST · A quote does not mean the product is available to trade on your account.
Opens 8:00 pm IST
Opens 8:00 pm IST
Opens 8:00 pm IST
In brief
Questions investors ask
Quotes run fifteen minutes behind.
1 month: +25.3% (SPY −1.6%, XLV +13.5%). 3 months: +22.6% (SPY −0.4%, XLV +15.5%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: MANE, SPY and XLV · as of 4 Nov 2026
The 4 Nov 2026 close of $136.51 was 17.2% above its 50-day average ($116.50).
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
3.7M shares were sold short at the 15 Oct 2026 settlement; covering them would take 3.8 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
July 16, 2026
−14.45%April 27, 2026
+47.55%April 10, 2026
+14.70%